Abiopharma

Ashiya Mona 🟢 acquired 66.3K shares (1 derivative) of Shattuck Labs, Inc. (STTK) at $0.99 Transaction Date: Aug 28, 2025 | Filing ID: 193328

Merck to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

New Form 3 - Shattuck Labs, Inc. Filed: 2025-09-02 AccNo: 0001193125-25-193318 Size: 15 KB

New Form 3 - Shattuck Labs, Inc. Filed: 2025-09-02 AccNo: 0001193125-25-193319 Size: 15 KB

Compass Pathways - Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

New Form 6-K - ICON PLC Filed: 2025-09-02 AccNo: 0001060955-25-000071 Size: 56 KB

New Form SCHEDULE 13G/A - Cyclacel Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026126 Size: 319 KB

New Form 6-K - ASTRAZENECA PLC Filed: 2025-09-02 AccNo: 0001654954-25-010235 Size: 20 KB

New Form SCHEDULE 13G/A - Cyclacel Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026123 Size: 319 KB

New Form 6-K - Haleon plc Filed: 2025-09-02 AccNo: 0001654954-25-010232 Size: 39 KB

New Form SCHEDULE 13G/A - Cyclacel Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026121 Size: 319 KB

New Form NT NPORT-P - DAXOR CORP Filed: 2025-09-02 AccNo: 0001641172-25-026120 Size: 10 KB

New Form 3 - Cyclacel Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026117 Size: 7 KB

New Form 3 - Cyclacel Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026116 Size: 7 KB